BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32548752)

  • 1. Reply to: "When Should Hepatectomy be Performed for the Treatment of Bismuth Type I and II Hilar Cholangiocarcinoma?".
    Li CX; Chen RX; Li XC
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):928-929. PubMed ID: 32548752
    [No Abstract]   [Full Text] [Related]  

  • 2. When Should Hepatectomy be Performed for the Treatment of Bismuth Type I and II Hilar Cholangiocarcinoma?
    Ma WJ; Li FY; Cheng NS
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):926-927. PubMed ID: 32394300
    [No Abstract]   [Full Text] [Related]  

  • 3. The "Hand as Foot" teaching method in Bismuth-Corlette classification of hilar cholangiocarcinoma.
    Fan S; Yang L; Cao X; Zhang X
    Asian J Surg; 2022 Jul; 45(7):1459-1460. PubMed ID: 35288006
    [No Abstract]   [Full Text] [Related]  

  • 4. Total three-dimensional laparoscopic radical resection for Bismuth type IV hilar cholangiocarcinoma.
    Liu YS; Qi DF; Zhang J; Li HS; Jiang XC; Cui L
    Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):541-546. PubMed ID: 36463067
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Left Trisectionectomy for Bismuth-Corlette Type IV Perihilar Cholangiocarcinoma with Left-Sided Predominance.
    Hosokawa I; Shimizu H
    Ann Surg Oncol; 2020 Jul; 27(7):2387-2388. PubMed ID: 32323086
    [No Abstract]   [Full Text] [Related]  

  • 6. [Benign hilar bile duct stricture resected as perihilar cholangiocarcinoma].
    Nagino M; Ebata T; Otsuka S
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(8):679-688. PubMed ID: 32779585
    [No Abstract]   [Full Text] [Related]  

  • 7. Fusion imaging of real-time ultrasonography and computed-tomography-assisted puncture of the bile duct of segment 6 for Bismuth-Corlette type IV perihilar cholangiocarcinoma.
    Hosokawa I; Takayashiki T; Ohtsuka M
    Asian J Surg; 2023 Feb; 46(2):907-908. PubMed ID: 35963681
    [No Abstract]   [Full Text] [Related]  

  • 8. Endovascular treatment of delayed arterial hemorrhage after radical operation for hilar cholangiocarcinoma.
    Wang XD; Ge NJ; He CJ; Zhu JJ; Xu W; Yang YF
    Hepatobiliary Pancreat Dis Int; 2023 Aug; 22(4):403-405. PubMed ID: 36858893
    [No Abstract]   [Full Text] [Related]  

  • 9. [The safety and effect of transhepatic hilar approach for the treatment of bismuth type Ⅲ and Ⅳ hilar cholangiocarcinoma].
    He M; Wang HL; Yan JY; Xu SW; Chen W; Wang J
    Zhonghua Wai Ke Za Zhi; 2018 May; 56(5):360-366. PubMed ID: 29779312
    [No Abstract]   [Full Text] [Related]  

  • 10. Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma.
    Deng Z; Zhao G; Wang Z; Yu L; Zou W; Li L; Liu R
    J Vis Exp; 2022 Jul; (185):. PubMed ID: 35913144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reply to comment on "surgical implications of the confluence patterns of the left intrahepatic bile ducts in right hepatectomy for perihilar cholangiocarcinoma".
    Hosokawa I; Ohtsuka M
    J Hepatobiliary Pancreat Sci; 2023 Feb; 30(2):e7-e8. PubMed ID: 35975954
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of secondary resection for patients with primary positive ductal margin of hilar cholangiocarcinoma: An updated meta-analysis.
    Dai YS; Hu HJ; Lv TR; Hu YF; Li FY
    Asian J Surg; 2022 Sep; 45(9):1780-1782. PubMed ID: 35422384
    [No Abstract]   [Full Text] [Related]  

  • 13. [Perihilar cholangiocarcinoma Bismuth type IV: Resection frequently possible].
    Strobel O; Büchler MW
    Chirurg; 2019 Mar; 90(Suppl 2):84. PubMed ID: 30758580
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term tumor-free survival after liver transplantation for the treatment of hilar cholangiocarcinoma: A case report.
    Huang XH; Jiang Y; Lv LZ; Hu HZ
    Asian J Surg; 2021 Aug; 44(8):1081-1082. PubMed ID: 34049790
    [No Abstract]   [Full Text] [Related]  

  • 15. Right trisectionectomy with caudate lobectomy and extrahepatic bile duct resection for type Y perihilar cholangiocarcinoma.
    Jeddou H; Tzedakis S; Boudjema K
    J Visc Surg; 2022 Dec; 159(6):502-510. PubMed ID: 35690583
    [No Abstract]   [Full Text] [Related]  

  • 16. Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases.
    Ikeyama T; Nagino M; Oda K; Ebata T; Nishio H; Nimura Y
    Ann Surg; 2007 Dec; 246(6):1052-7. PubMed ID: 18043110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Operation treatment method of Bismuth-Corlette Ⅲ, Ⅳ hilar cholangiocarcinoma].
    Lu Z; Wang DD
    Zhonghua Wai Ke Za Zhi; 2016 Jul; 54(7):488-91. PubMed ID: 27373472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized Approach to the Management of Hilar Cholangiocarcinoma: How We Do It.
    Buerlein RCD; Podboy AJ; Strand DS
    Am J Gastroenterol; 2023 Dec; 118(12):2101-2105. PubMed ID: 37126854
    [No Abstract]   [Full Text] [Related]  

  • 19. Anatomical Basis of Routine Caudate Lobe Resections in Hilar Cholangiocarcinoma.
    Jain V; Krishnamurthy G; Kumar H; Sahni D; Gorsi U; Yadav TD; Singh H
    J Gastrointest Surg; 2021 Aug; 25(8):2114-2115. PubMed ID: 33547586
    [No Abstract]   [Full Text] [Related]  

  • 20. The Role of Surgery in the Treatment of Bismuth-Corlette Type IV Perihilar Cholangiocarcinoma.
    Alaimo L; Bagante F; Ruzzenente A
    Ann Surg Oncol; 2021 Nov; 28(12):7730. PubMed ID: 33881654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.